Treace Medical Concepts, Inc.
Terry Lubben has extensive experience in operations, supply chain management, and strategic development. Terry began their career at Medtronic in 1994, where they served as the Director of Supply Chain Strategies and Technologies. During their time at Medtronic, they were responsible for transitioning to a new global SAP system and played a key role in business development and acquisitions. Lubben then moved on to serve as the Vice President and General Manager at Lakewood Products and later as the Global Production Procurement and Systems leader at The Toro Company. Terry joined superDimension as the Director of Supply Chain Management in 2009, where they oversaw all aspects of the supply chain. After superDimension was acquired by Covidien, they continued to work for the company as the Senior Director of Operations / V.P. Supply Chain Management. In this role, they implemented various improvements, including level-loading production schedules and establishing monthly S&OP meetings. Lubben later joined Medtronic again as the Sr. Director of Operations, where they led various departments and projects. Terry then transitioned to Smiths Medical as the Vice President of Global Sourcing, where they sourced and launched new products, reduced costs, and developed category management strategies. Lubben then joined Cantel Medical as the Senior Vice President of Operations and Global Supply Chain, where they implemented cost and cash-saving measures and improved working capital. Currently, they are serving as the Senior Vice President and Chief Operating Officer at Treace Medical Concepts, Inc., where they lead the company's operations, supply chain, and customer service functions.
Terry Lubben obtained an MBA in Business from Grand Valley State University. No specific timeline or duration of study was mentioned.
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.